MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells

被引：0
|
作者：
Yuxia Li
Jie Zhang
Yajing Liu
Bingyue Zhang
Fubo Zhong
Shubin Wang
Zhengyu Fang
机构：
[1] Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center,Biomedical Research Institute
[2] Peking University Shenzhen Hospital,Department of Medical Oncology
来源：
BMC Cancer | / 18卷
关键词：
Melanoma; Cisplatin; miR-30a-5p; IGF1R; Chemo-resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
    Li, Yuxia
    Zhang, Jie
    Liu, Yajing
    Zhang, Bingyue
    Zhong, Fubo
    Wang, Shubin
    Fang, Zhengyu
    BMC CANCER, 2018, 18
  • [2] MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
    Zhang, Yong
    Huang, Sanxiu
    Guo, Yu
    Li, Lingfeng
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 1357 - 1363
  • [3] MiR-30a-5p accelerates adipogenesis by negatively regulating Sirtuin 1
    Cui, Shanshan
    Soni, Chaitanya Brijmohan
    Xie, Juan
    Li, Yongmei
    Zhu, Hong
    Wu, Fei
    Zhi, Xinyue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (11): : 5203 - 5212
  • [4] Expression of miR-30a-5p in Expression of Mir-30A-5P in Extracellular Vesicle as a Prognostic Biomarker for Non Small Cell Lung Cancer Therapy
    Pangaribuan, M. T. G.
    Zaini, J.
    Sutandyo, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S504 - S504
  • [5] Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R
    Bugide, Suresh
    Parajuli, Keshab Raj
    Chava, Suresh
    Pattanayak, Rudradip
    Della Manna, Deborah L.
    Shrestha, Deepmala
    Yang, Eddy S.
    Cai, Guoping
    Johnson, Douglas B.
    Gupta, Romi
    ONCOGENESIS, 2020, 9 (05)
  • [6] Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R
    Suresh Bugide
    Keshab Raj Parajuli
    Suresh Chava
    Rudradip Pattanayak
    Deborah L. Della Manna
    Deepmala Shrestha
    Eddy S. Yang
    Guoping Cai
    Douglas B. Johnson
    Romi Gupta
    Oncogenesis, 9
  • [7] miR-100-5p Inhibits Malignant Behavior of Chordoma Cells by Targeting IGF1R
    Zhang, Hongliang
    Yang, Kang
    Ren, Tingting
    Huang, Yi
    Liang, Xin
    Yu, Yiyang
    Wang, Wei
    Niu, Jianfang
    Lou, Jingbing
    Tang, Xiaodong
    Guo, Wei
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4129 - 4137
  • [8] Overexpression of miR-199a-5p confers cisplatin resistance in ovarian cancer cells by regulating GSK-3β
    Li, Yueran
    Xiao, Songshu
    Pan, Qiong
    Ye, Mingzhu
    He, Sili
    Tian, Qi
    Xue, Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13180 - 13189
  • [9] MiR-30a-5p Enhances Cisplatin Sensitivity by Downregulating RIF1 in Ovarian Cancer
    Yao, Wenlei
    Wang, Yongfang
    Huang, Mei
    Zhou, Jianbo
    Zheng, Renshan
    Jin, Cuiping
    Zhang, Yanhua
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2023, 53 (03): : 418 - 426
  • [10] Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2
    Zhuang, Ming
    Shi, Qin
    Zhang, Xiuwei
    Ding, Yongbin
    Shan, Liuqun
    Shan, Xia
    Qian, Jiaqi
    Zhou, Xin
    Huang, Zebo
    Zhu, Wei
    Ding, Yin
    Cheng, Wenfang
    Liu, Ping
    Shu, Yongqian
    TUMOR BIOLOGY, 2015, 36 (04) : 2737 - 2745
12345